RepliCel Life Sciences Inc.
OTC: REPCF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Andrew Schutte
- Employees
- 1
- Headquarters
- Vancouver, Canada
- IPO year
- 2010
- Market cap
- $7.0K
- Website
- https://www.replicel.com
Loading REPCF…
Loading profile data…Frequently asked questions about REPCF
What does RepliCel Life Sciences Inc. (REPCF) do?
RepliCel Life Sciences Inc., a biotechnology firm based in Vancouver, Canada, specializes in regenerative medicine. The company focuses on developing patient-specific cell therapies designed to address functional cellular deficits. Their treatment methodology involves extracting an individual's own cells from harvested bodily tissues and then cu...
Where does REPCF trade?
RepliCel Life Sciences Inc. (REPCF) trades on the Other OTC.
What sector is REPCF in?
RepliCel Life Sciences Inc. (REPCF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of RepliCel Life Sciences Inc.?
Andrew Schutte is the chief executive officer of RepliCel Life Sciences Inc. (REPCF).
Where is RepliCel Life Sciences Inc. headquartered?
RepliCel Life Sciences Inc. is headquartered in Canada.
Does REPCF pay a dividend?
RepliCel Life Sciences Inc. (REPCF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did REPCF go public?
RepliCel Life Sciences Inc. (REPCF) completed its initial public offering in 2010.